期刊文献+

铁对人肺癌细胞及肿瘤血管内皮细胞模型增殖活性的影响

Effects of iron on proliferation activity of human lung adenocarcinoma cell SPC-A-1 and tumor vascular endothelial cells
下载PDF
导出
摘要 目的研究铁对体外培养的人肺腺癌细胞SPC-A-1及肿瘤血管内皮细胞模型增殖活性的影响。方法采用四甲基偶氮唑盐(MTT)法检测人肺腺癌细胞SPC-A-1及肿瘤血管内皮细胞模型的增殖活性,流式细胞仪检测铁对SPC-A-1细胞周期和细胞凋亡的效应。结果 10、30、100及300 mol/L浓度组铁可明显促进SPC-A-1细胞的增殖活性;10、30及100 mol/L浓度组铁使SPC-A-1的G1期细胞比例减少,S期和G2期细胞比例增多;30及100 mol/L浓度组铁使SPC-A-1的凋亡率显著降低;30及100 mol/L的铁可明显促进肿瘤血管内皮细胞的增殖活性。结论铁可通过促进肿瘤细胞向S期转化、降低凋亡率从而促进SPC-A-1细胞增殖,还可通过刺激血管内皮细胞的增殖促进肿瘤的增长。 Objective To study the effect of iron on the proliferation of human lung adenocarcinoma cell SPC-A- 1 and tumor vascular endothelial cells. Methods Proliferation activity of SPC-A-1 and tumor vascular endothelial cells was monitored by MTT assay. Flow cytometry was performed to measure the cell cycle and apoptosis. Results Iron at 101μmol/L, 30μmol/L, 1001μmol/L, 3001μmol/L concentration significantly increased proliferation of SPC- A-1. Iron at 101μmol/L, 301μmol/L, 100 1μmol/L concentration decreased the cell counts in G1 phase while it increased the cell counts in S phase and G2 phase. Iron at 30 1μmol/L, 100 1μmol/L concentration reduced the ratio of apoptosis of SPC-A-1. The proliferation of tumor vascular endothelial cells were obviously increased in iron groups at 30 1μmol/L, 1001μmol/L concentration. Conclusions Iron could increase the proliferation of SPC-A- 1 by prompting the cells en- tering S phase and reducing the ratio of cell apoptosis. Iron could also increase the growth of tumor through promoting the proliferation of tumor vascular endothelial cells.
作者 况炜 陈慧玲
出处 《现代实用医学》 2013年第3期251-253,共3页 Modern Practical Medicine
基金 宁波市医学科技项目(200555 2009B14) 浙江省高校青年教师资助计划 浙江省教育厅科研项目(20071357)
关键词 肺癌细胞 肿瘤血管内皮细胞 Iron Neoplasm Vascular endothelial Cells
  • 相关文献

参考文献9

  • 1Buss JL, Torti FM, Torti SV. The role of iron chelation in cancer therapy[J]. Current Medicinal Chemistry, 2003, 10(12): 1021-1034.
  • 2Yuan J, Lovejoy DB, Richardson DR. Novel di-2-pyridyl-derived- iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment[J]. Blood, 2004, 104(5):1450-1458.
  • 3Kontoghiorghes GJ, Efstathiou A, Ioannou-Loucaides S, et al. Che- lators controlling metal metabolism and toxicity pathways: applic- ations in cancer prevention, diagnosis and treatment[J]. Hemoglo- bin,2008,32(1-2):217-227.
  • 4Tosetti F, Ferrari N, De Flora S, et al. Angioprevention: angiogen- esis is a common and key target for cancer chemopre ventive agents [J]. Faseb Journal,2002,16( 1 ):2-14.
  • 5Carlini RG, Alonzo E, Bellorin-Font E, et al. Apoptotic stress pat- hway ctivation mediated by iron on endothelial cells in vitro[J]. Nephrol Dial Transplant,2006,21 (11):3055-3061.
  • 6Simonart T, DegraefC, Andrei G, et al. Iron chelators inhibit the growth and induce the apoptosis of Kaposi's sarcoma cells and of their putative endothelial precursors[J]. The joumal of Investigative Dermatology,2000,115(5): 893 -900.
  • 7Milovanova T, Chatterjee S, Manevich Y, et al. Lung endothelial cell proliferation with decreased shear stress is mediated by reactive oxygen species[J]. American journal of physiology-Cell physio- logy,2006,290(1): 66-76.
  • 8Guo AM, Arbab AS, Falck JR, et al. Activation of vascular endo- thelial growth factor through reactive oxygen species mediates 20- hydroxyeicosatetraenoic acid-induced endothelial cell proliferation [J]. 1hejouml Ymnacok d 2007, 321(1.18-21.
  • 9况炜,陈莹莹,沈岳良,夏强.铁抑制血管舒张活动及其作用机制[J].中国病理生理杂志,2003,19(11):1480-1483. 被引量:8

二级参考文献6

  • 1Lekakis J,Papamicheal C,Stamatelopoulos K,et al.Hemochromatosis associated with endothelial dysfunction:evidence for the role of iron stores in early atherogenesis[J],Vasc Med, 1999, 4(3): 147- 148.
  • 2Duffy SJ, Biegelsen ES, Holbrook M, et al. Iron chelation improves endothelial function in patients with coronary artery disease[J]. Circulation, 2001, 103(23) : 2799- 2804.
  • 3Doyle MP, Duling BR. Acetylcholine induces concucted vasodilation by nitric oxide - dependent and -independent mechanisms[J]. Am J Physiol, 1997, 272(3 Pt 2): H1364- H1371.
  • 4Griffon B, Cillard J,Chevanne M,et al.Macrophage-induced inhibition of nitric oxide production in primary rat hepatocyte cultures via prostaglandin E2 release[J],Hepatology,1998, 28(5) : 1300 - 1308.
  • 5Duval DL,Sieg DJ,Billings RE,Regulation of hepatic nitric oxide synthase by reactive oxygen i9ntermediates and glutathione[J],Arch Biochem Biophys, 1995, 316(2): 699-706.
  • 6Park SH, Aust AE. Regulation of nitric oxide synthase induction by iron and glutathione in asbestos-treated human lung epithelial cells[J]. Arch Biochem Biophys, 1998, 360(1):47 - 52.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部